(Q36570330)

English

Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).

scientific article published on December 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866). (English)

1 reference

Europe PubMed Central

15 August 2017

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Joanne Kurtzberg

1

object named as

Joanne Kurtzberg

1 reference

Europe PubMed Central

15 August 2017

author name string

Barbara Asselin

2

1 reference

Europe PubMed Central

15 August 2017

Mark Bernstein

3

1 reference

Europe PubMed Central

15 August 2017

George R Buchanan

4

1 reference

Europe PubMed Central

15 August 2017

Brad H Pollock

5

1 reference

Europe PubMed Central

15 August 2017

Bruce M Camitta

6

1 reference

Europe PubMed Central

15 August 2017

publication date

1 December 2011

1 reference

Europe PubMed Central

15 August 2017

Journal of Pediatric Hematology/Oncology

1 reference

Europe PubMed Central

15 August 2017

33

1 reference

Europe PubMed Central

15 August 2017

8

1 reference

Europe PubMed Central

15 August 2017

610-616

1 reference

Europe PubMed Central

15 August 2017

The three asparaginases. Comparative pharmacology and optimal use in childhood leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

30 September 2017

Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

30 September 2017

Use of ?-asparaginase in childhood ALL

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

30 September 2017

Asparaginase revisited

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

30 September 2017

Treatment of adult leukemia with L-asparaginase (NSC-109229)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

30 September 2017

E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

30 September 2017

Toxicity of E. coli L-asparaginase in man

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

30 September 2017

More is better! Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

30 September 2017

Vincristine and prednisone vs vincristine, l-asparaginase, and prednisone for second remission induction of acute lymphocytic leukemia in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

30 September 2017

Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Childrens Cancer Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

30 September 2017

Improvement in the therapeutic, immunological, and clearance properties of Escherichia coli and Erwinia carotovora L-asparaginases by attachment of poly-DL-alanyl peptides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

30 September 2017

Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

30 September 2017

An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

28 June 2018

The antitumor activity of Escherichia coli L-asparaginase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

28 June 2018

Toxic and antineoplastic effects of L-asparaginase. Study of mice with lymphoma and normal monkeys and report on a child with leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

28 June 2018

L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

28 June 2018

Toxicity of L-asparaginase in children with advanced leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

28 June 2018

Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

28 June 2018

Treatment of L5178Y tumor-bearing BDF1 mice with a nonimmunogenic L-glutaminase-L-asparaginase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

28 June 2018

Human pharmacology and toxicology of succinylated Acinetobacter glutaminase-asparaginase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

28 June 2018

Allergic reactions to E. coli L-asparaginase do not affect outcome in childhood B-precursor acute lymphoblastic leukemia: a Children's Oncology Group Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

21 September 2018

Consolidation therapy with antimetabolite-based therapy in standard-risk acute lymphocytic leukemia of childhood: a Pediatric Oncology Group Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

21 September 2018

Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

21 September 2018

Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557823

21 September 2018

L-Asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-asparaginase conjugates

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reinduction therapy in 297 children with acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-randomised study comparing toxicity of Escherichia coli and Erwinia asparaginase in children with leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative pharmacokinetic studies of three asparaginase preparations

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of relapsed infant acute lymphoblastic leukemia with intensive antimetabolite-based chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose cytosine arabinoside and L-asparaginase in refractory acute lymphoblastic leukemia: the Children's Cancer Group experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity, pharmacology and feasibility of administration of PEG-L-asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic dose adjustment of Erwinia asparaginase in protocol II of the paediatric ALL/NHL-BFM treatment protocols

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy with Erwinia L-asparaginase in children with acute leukemia after anaphylaxis to E. coli L-asparaginase

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two L-asparaginases from Escherichia coli B. Their separation, purification, and antitumor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of leukemias in man by L-asparaginase

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

L-asparagine requirement and the effect of L-asparaginase on the normal and leukemic human bone marrow

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

L-asparaginase: clinical, biochemical, pharmacological, and immunological studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of anaphylactic reactions to asparaginase derived from Escherichia coli and from Erwinia cultures

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved treatment results in the management of single and multiple relapses of acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/MPH.0B013E31822D4D4E

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36570330&oldid=2123254674"